" class="no-js "lang="en-US"> Caris Life Sciences Announces Appointment of Rob Clark as Chief Communications Officer - Medtech Alert
Thursday, June 20, 2024

Caris Life Sciences Announces Appointment of Rob Clark as Chief Communications Officer

Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today the appointment of Rob Clark as Senior Vice President and Chief Communications Officer.

“As a molecular science powerhouse, Caris is leading a revolution in healthcare with novel approaches to categorize, visualize and target disease in ways never before possible,” said David D. Halbert, Chairman and CEO of Caris Life Sciences. “We are very excited to welcome Rob to Caris. His strong expertise in communications and public policy will help position us to further advance our mission to improve the lives of as many people as possible.”

Mr. Clark brings to Caris more than 20 years of communications, marketing and public policy experience spanning the healthcare, telecommunications and energy sectors. He will lead the company’s communications, corporate marketing and government relations efforts.

“I am thrilled to join the women and men of Caris, who are committed to helping physicians and patients apply the best science and technology to better diagnose and treat a range of conditions,” said Clark. “I look forward to working with David, the entire management team and the people of Caris to help the company reach its full potential and positively impact lives around the world.”

Mr. Clark joins Caris from ExxonMobil, where he served as Head of Global Communications. In this role, Clark led the company’s efforts across public and media relations, advertising, digital and social media, and employee and executive communications. Prior to his time at ExxonMobil, Mr. Clark led the global corporate communications and marketing functions as Chief Communications Officer of Medtronic, a global leader in medical technology. While at Medtronic, Mr. Clark led the company’s communications efforts for Medtronic’s 2015 $50 billion acquisition of Covidien, the company’s subsequent rebranding, and the launch of numerous new technology offerings and platforms.

Mr. Clark, a U.S. Air Force veteran, holds a BA in English from The Virginia Military Institute and a master’s degree in Political Science from the University of South Dakota. He is a member of the Arthur Page Society, a trustee to the Institute for Public Relations and a member of the Dean’s Advisory Committee at the University of Florida School of Communications and Journalism.

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more